Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion-weighted 3 tesla MR imaging

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 1, 2012, Pages 110-116

  Jung, Se Hee ^a   Heo, Suk Hee ^b   Kim, Jin Woong ^b   Jeong, Yong Yeon ^b   Shin, Sang Soo ^c   Soung, Min Gyu ^d   Kim, Heong Rok ^b   Kang, Heoung Keun ^b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

chemoradiation therapy; diffusion weighted imaging; magnetic resonance imaging; rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; PREDICTION; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; CHEMORADIOTHERAPY; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 83755225111     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22749     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smith AJ, Law CH,. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006; 98: 1474-1481. (Pubitemid 44605592)
3. Heald RJ, Ryall RD,. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482. (Pubitemid 16095660)
4. Reerink O, Verschueren RC, Szabo BG, Hospers GA, Mulder NH,. A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 2003; 39: 192-195. (Pubitemid 36057069)
5. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
6. Dresen RC, Beets GL, Rutten HJ, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009; 252: 71-80.
7. Miao H, Fukatsu H, Ishigaki T,. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007; 61: 297-302. (Pubitemid 46096691)
8. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56: 958-965. (Pubitemid 36794026)
9. Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003; 45: 214-222. (Pubitemid 36197717)
10. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009; 253: 116-125.
11. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170-178.
12. Lambrecht M, Deroose C, Roels S, et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol 2010; 49: 956-963.
13. Le Bihan D,. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995; 8: 375-386.
14. Dworak O, Keilholz L, Hoffmann A,. Pathologic features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23. (Pubitemid 27138353)
15. Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009; 250: 730-739.
16. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504. (Pubitemid 32173585)
17. Kim CK, Kim SH, Chun HK, et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 2006; 16: 972-980.
18. Blomqvist L, Holm T, Rubio C, Hindmarsh T,. Rectal tumours-MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997; 38: 437-444. (Pubitemid 127452155)
19. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504. (Pubitemid 32173585)
20. Gagliardi G, Bayar S, Smith R, Salem RR,. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Sur 2002; 137: 447-451. (Pubitemid 34650154)
21. Poon FW, McDonald A, Anderson JH, et al. Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer. Eur J Radiol 2005; 53: 256-262. (Pubitemid 40143587)
22. Miller AB, Hoogstraten B, Staquet M, Winkler A,. Reporting results of cancer treatment. Cancer 1981; 47: 207-214. (Pubitemid 11167383)
23. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
24. Van Hoe L, Haven F, Bellon E, et al. Factors influencing the accuracy of volume measurements in spiral CT: a phantom study. J Comp Assist Tomogr 1997; 21: 332-338. (Pubitemid 27120046)
25. Van Hoe L, Van Cutsem E, Vergote I, et al. Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT. Radiology 1997; 202: 671-675. (Pubitemid 27093435)
26. Torkzad MR, Lindholm J, Martling A, Cedermark B, Glimelius B, Blomqvist L,. MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol 2007; 17: 1566-1573. (Pubitemid 46767605)
27. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-1635. (Pubitemid 46866868)
28. Chang KJ, Kamel IR, Macura KJ, Bluemke DA,. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics 2008; 28: 1983-1998.
29. Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR,. Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics 2009; 29: 1547-1563.
30. Mardor Y, Roth Y, Ochershvilli A, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004; 6: 136-142. (Pubitemid 38544601)
31. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001-1008. (Pubitemid 46496932)
32. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307-308. (Pubitemid 34874724)
33. Harrison L, Blackwell K,. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004; 9: 31-40. (Pubitemid 39658343)
34. Harry VN, Semple SI, Gilbert FJ, Parkin DE,. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008; 111: 213-220.
35. Niwa T, Ueno M, Ohkawa S, et al. Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. Br J Radiol 2009; 82: 28-34.
36. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004; 17: 249-259. (Pubitemid 40362308)
37. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005; 102: 5524-5529. (Pubitemid 40530291)